AYR Wellness has become a familiar name across South Florida since acquiring Liberty Health Sciences in 2021 and rebranding its Florida retail network under the AYR Cannabis Dispensary banner. With dozens of storefronts stretching from Miami-Dade through Broward, Palm Beach and down to the Keys, AYR is one of the state’s largest medical operators by store count and weekly sales volume. Below is a concise look at its South Florida presence, the company’s latest revenue, how industry “top five” standings are determined in Florida, and what sets AYR’s shops apart.

A dense South Florida footprint

AYR operates multiple dispensaries in Miami-Dade, Broward, Palm Beach and Monroe counties, including (among others) Miami (Bird Road), North Miami, Hollywood, West Palm Beach, Palm Beach Gardens, and Key West. These stores offer in-store shopping, pickup, and typical Florida medical-menu formats. SITE: ayrdispensaries.com

Statewide, AYR lists 67 Florida locations on its corporate and retail pages—consistent with the Florida regulator’s weekly update that shows 67 dispensing locations for “Ayr Cannabis Dispensary.” That places AYR among the largest retail footprints in the state.

How they got here: AYR entered Florida at scale by acquiring Liberty Health Sciences (LHS) in early 2021—an all-stock deal that folded LHS’s stores and cultivation assets into AYR’s vertically integrated platform.

Revenue: the latest full-year number

For the full year 2024, AYR Wellness reported $463.6 million in revenue (flat year-over-year), with Q4 2024 revenue of ~$114 million. The company also disclosed a $94 million goodwill impairment related to Florida recorded in Q4 2024, reflecting market conditions at the time.

Independent trackers show a similar 2024 revenue run-rate in the $460+ million range (TTM), corroborating the figures in AYR’s filings and investor communications. READ MORE: CompaniesMarketCap

Are they a “top five” operator in Florida?

In Florida, the most widely followed proxy for who’s “top” is the weekly OMMU (Office of Medical Marijuana Use) Update. It lists, by licensed MMTC (Medical Marijuana Treatment Center), the number of dispensing locations and weekly dispensations (milligrams of THC/CBD and ounces of smokable flower). Trade outlets and analysts regularly use this public data stream to compare operators by scale and sell-through. READ MORE: Medical Marijuana Use Florida

In the September 5, 2025 OMMU report (week of Aug. 29–Sept. 4), AYR ranked squarely within the top five on multiple volume metrics:

• Medical marijuana (mg THC): AYR reported 39.4 million mg THC, trailing Trulieve and MÜV—and competing closely with Curaleaf and Surterra.
• Smokable flower (ounces): AYR reported 9,436 oz, again within the top cluster after Trulieve, Curaleaf and MÜV.
• Store count: 67 dispensing locations, tied with Curaleaf and behind Trulieve and MÜV.

Because these OMMU tables are state-published and refreshed weekly, they’re the de facto scoreboard. Media outlets and investors generally treat OMMU as the arbiter for Florida rankings by actual sell-through and retail scale, rather than self-reported company claims. On that basis, AYR is consistently a top-five operator by weekly dispensations and footprint.

What AYR’s South Florida stores look and feel like

AYR’s Florida chain emphasizes bright, clinic-meets-boutique interiors, private consultation rooms, and standardized menus that mirror the company’s scaled cultivation and manufacturing. The retail pages highlight patient-first service (discount programs, rewards) and a wide assortment across form factors (flower, vapes, concentrates, edibles, tinctures, topicals).

Several South Florida locations feature neighborhood-specific touches—e.g., high-traffic corridor access in Hollywood (downtown), a Bird Road location serving central Miami, and a Key West storefront on Duval Street aimed at convenience and tourist footfall within Monroe County.

What stands out as “signature” to AYR in Florida

1) House brands and exclusive partnerships
AYR pushes a portfolio of in-house brands such as kynd (gummies/tinctures), Haze (concentrates and vapes), and others that rotate by state compliance. In 2024, AYR launched kynd gummies in Florida—positioning tiered SKUs (UPLIFT/BALANCE/RELAX) that match patient use-cases and simplify dosing. Some AYR Florida menus also carry Camino (Kiva) edibles under an exclusive availability note, giving shoppers a recognizable national edible line in-store.

2) Scale and consistency
With 67 storefronts and centralized production, AYR leans on supply consistency—same strains and SKUs across markets—so patients in Miami, Broward or Palm Beach see stable availability and pricing across stores. The OMMU’s weekly volumes reinforce that AYR moves meaningful units relative to peers, a good indicator of inventory depth.

3) Keys & tourist-adjacent access
The Key West (Duval Street) location is an outlier that many operators don’t have, creating a down-the-archipelago presence that can service locals and visitors with medical cards who need convenient access at Florida’s southern tip.

Competitive context in South Florida

South Florida is intensely competitive, with Trulieve, Curaleaf, MÜV (Verano), Surterra (Parallel), Fluent, Sunnyside (Cresco) and others clustering stores across Miami-Dade, Broward and Palm Beach. The OMMU’s weekly data shows a four-operator top tier on volume—Trulieve, Curaleaf, MÜV, and AYR—followed by a dense mid-pack. AYR’s advantage is a broad footprint plus brand depth, while its challenge is the same one facing all operators: price compression and patient growth moderating as the market matures.

Outlook: what to watch

• Store optimization vs. blanket expansion. AYR has opened selectively in 2024–2025 (including new Miami retail), but the Florida market is in a phase where same-store growth, merchandising and cost control often matter more than raw store count.
• Product mix and brand pull. As edibles and solventless categories expand in patient demand, AYR’s house-brand strategy (e.g., kynd, Haze) and selective third-party exclusives (like Camino in certain stores) can be differentiators—if supply remains consistent.
• Macro headwinds. AYR disclosed a Florida goodwill impairment in Q4 2024, a reminder that pricing pressure, regulatory costs, and the cadence of new patient sign-ups affect profitability. The company is pursuing facility upgrades (IIP financing for Florida cultivation) to support quality and throughput in 2025+.

Bottom line

Across South Florida, AYR Wellness has built a large, stable retail network with recognizable brands and consistent menus. The company reported $463.6 million in 2024 revenue and—by the only scoreboard that really counts in Florida, the OMMU weekly dispensations—AYR sits firmly in the state’s top five operators by both store count and sell-through. If you’re benchmarking operators with real traction from Miami through Palm Beach (and even down in Key West), AYR belongs on the short list.